General
Cuban COVID-19 vaccine maker announces jab candidate showing 92 per cent efficacy
Cuba’s Abdala coronavirus candidate vaccine shows more than 92 per cent efficacy after three doses, its maker says.
Key points:
- Cuba is developing five vaccines, including two that are already being rolled out to the population
- The BioCubaFarma laboratory says the Abdala vaccine is 92.28 per…
Continue Reading
-
Business23 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News22 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News23 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News21 hours agoBrisbane news live: Broken-down train causes peak-hour delays